In Pharma/Biotech Co-Promotion Agreements, Specificity Is The Best Policy
This article was originally published in The Pink Sheet Daily
Executive Summary
Allergan, Genentech execs recommend clear definitions of roles and responsibility at the outset of deals between pharma and biotech.